The investigators and their sponsoring institutions received $5,000 to $250,000 each, according to a July 11 news release. Applications were reviewed and scored by scientists and clinician scientists.
The principal investigators and their projects are:
1. Kyle Duchman, MD, for “Platelet Rich Plasma for Osteoarthritis: Role of Exosomes in Effectiveness”
2. Muhammad Farooq Rai, PhD, for “KLF10 as a Novel Therapeutic Target in Osteoarthritis”
3. Cecilia Pascual Garrido, MD, PhD, for “Epigenetic Regulation of Key Molecular Players in the Progression of Hip OA”
4. Paul Courtney, MD, for “Impact of Prior Authorization of Patient Care and Outcomes in Orthopaedics”
5. Aaron Hoyt, MD, for “In Vitro Thermal Stability of Dalbavancin in PMMA Cement”
6. David Liu, MD, for “Value of Vitamin D in Prevention and Treatment of Pediatric Fractures”
7. Arakua Welbeck, MD, for “Wearable Sensors to Measure Function after Brachial Plexus Reconstruction”
8. Brian Yang, MD, for “Tenodesis Effect as a Diagnostic Test to Detect Occult Dorsal Ganglion Cyst”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
